Cargando…

Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy

Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H. polygyrus (HES) potently suppress inflammation induced by allergens from the common...

Descripción completa

Detalles Bibliográficos
Autores principales: McSorley, H J, Blair, N F, Smith, K A, McKenzie, A N J, Maizels, R M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016792/
https://www.ncbi.nlm.nih.gov/pubmed/24496315
http://dx.doi.org/10.1038/mi.2013.123
_version_ 1782315564338774016
author McSorley, H J
Blair, N F
Smith, K A
McKenzie, A N J
Maizels, R M
author_facet McSorley, H J
Blair, N F
Smith, K A
McKenzie, A N J
Maizels, R M
author_sort McSorley, H J
collection PubMed
description Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H. polygyrus (HES) potently suppress inflammation induced by allergens from the common fungus Alternaria alternata. Alternaria extract, when administered to mice intranasally with ovalbumin (OVA) protein, induces a rapid (1–48 h) innate response while also priming an OVA-specific Th2 response that can be evoked 14 days later by intranasal administration of OVA alone. In this model, HES coadministration with Alternaria/OVA suppressed early IL-33 release, innate lymphoid cell (ILC) production of IL-4, IL-5, and IL-13, and localized eosinophilia. Upon OVA challenge, type 2 ILC (ILC2)/Th2 cytokine production and eosinophilia were diminished in HES-treated mice. HES administration 6 h before Alternaria blocked the allergic response, and its suppressive activity was abolished by heat treatment. Administration of recombinant IL-33 at sensitization with Alternaria/OVA/HES abrogated HES suppression of OVA-specific responses at challenge, indicating that suppression of early Alternaria-induced IL-33 release could be central to the anti-allergic effects of HES. Thus, this helminth parasite targets IL-33 production as part of its armory of suppressive effects, forestalling the development of the type 2 immune response to infection and allergic sensitization.
format Online
Article
Text
id pubmed-4016792
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40167922014-09-01 Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy McSorley, H J Blair, N F Smith, K A McKenzie, A N J Maizels, R M Mucosal Immunol Article Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H. polygyrus (HES) potently suppress inflammation induced by allergens from the common fungus Alternaria alternata. Alternaria extract, when administered to mice intranasally with ovalbumin (OVA) protein, induces a rapid (1–48 h) innate response while also priming an OVA-specific Th2 response that can be evoked 14 days later by intranasal administration of OVA alone. In this model, HES coadministration with Alternaria/OVA suppressed early IL-33 release, innate lymphoid cell (ILC) production of IL-4, IL-5, and IL-13, and localized eosinophilia. Upon OVA challenge, type 2 ILC (ILC2)/Th2 cytokine production and eosinophilia were diminished in HES-treated mice. HES administration 6 h before Alternaria blocked the allergic response, and its suppressive activity was abolished by heat treatment. Administration of recombinant IL-33 at sensitization with Alternaria/OVA/HES abrogated HES suppression of OVA-specific responses at challenge, indicating that suppression of early Alternaria-induced IL-33 release could be central to the anti-allergic effects of HES. Thus, this helminth parasite targets IL-33 production as part of its armory of suppressive effects, forestalling the development of the type 2 immune response to infection and allergic sensitization. Nature Publishing Group 2014-09 2014-02-05 /pmc/articles/PMC4016792/ /pubmed/24496315 http://dx.doi.org/10.1038/mi.2013.123 Text en Copyright © 2014 Society for Mucosal Immunology http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/.
spellingShingle Article
McSorley, H J
Blair, N F
Smith, K A
McKenzie, A N J
Maizels, R M
Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
title Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
title_full Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
title_fullStr Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
title_full_unstemmed Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
title_short Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
title_sort blockade of il-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016792/
https://www.ncbi.nlm.nih.gov/pubmed/24496315
http://dx.doi.org/10.1038/mi.2013.123
work_keys_str_mv AT mcsorleyhj blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy
AT blairnf blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy
AT smithka blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy
AT mckenzieanj blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy
AT maizelsrm blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy